$4.16
0[0.00%]
At close: Apr 26
$4.16
0[0.00%]
After Hours: 6:37PM EDT
BioCryst Pharma
(NASDAQ:BCRX)BioCryst Pharma Stock (NASDAQ:BCRX), Insider Trading Activity
BioCryst Pharma: Insider buying and selling updated today.
Insider Shares Owned
6.152M
Insider Percentage Owned
2.98%
Institutional Shares Held
95.876M
Institutional Percentage Held
46.5%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | MACHELLE SANDERS | DIRECTOR | 12.745K | $7.98 | -$31.92K | GRANT | 99.06% | 25.611K | Jun 13 - Jun 15 | View |
| Jun 15, 2023 | Nancy Hutson | DIRECTOR | 3.879K | $8.04 | -$103.44K | GRANT | 4.98% | 81.818K | Jun 13 - Jun 14 | View |
| Apr 05, 2023 | Helen Thackray | CHIEF R&D OFFICER | -7K | $8.29 | -$58.03K | SELL | -3.27% | 207.275K | Apr 03 | View |
| Feb 02, 2023 | Jon Stonehouse | PRESIDENT & CEO | 0 | $7.92 | -$493.00K | SELL-OPTIONS | 0.00% | 1.008739M | Dec 29 - Feb 01 | View |
| Dec 19, 2022 | Jon Stonehouse | PRESIDENT & CEO | -14.1K | $10.90 | -$153.69K | SELL | -1.55% | 892.73K | Dec 15 | View |
| Dec 19, 2022 | Helen Thackray | CHIEF R&D OFFICER | -3.125K | $10.89 | -$34.03K | SELL | -2.29% | 133.275K | Dec 15 | View |
| Dec 19, 2022 | Anthony Doyle | CHIEF FINANCIAL OFFICER | -5.7K | $10.90 | -$62.13K | SELL | -3.36% | 163.966K | Dec 15 | View |
| Dec 19, 2022 | Charles Gayer | CHIEF COMMERCIAL OFFICER | -6.1K | $10.90 | -$66.49K | SELL | -2.80% | 211.61K | Dec 15 | View |
| Dec 19, 2022 | Michael Jones | EXEC. DIRECTOR, FINANCE - PAO | -445 | $10.90 | -$4.85K | SELL | -3.97% | 10.753K | Dec 15 | View |
| Dec 19, 2022 | Alane P Barnes | CHIEF LEGAL OFFICER | -4.175K | $10.88 | -$45.42K | SELL | -2.06% | 198.77K | Dec 15 | View |
| Dec 02, 2022 | Michael Jones | EXEC. DIRECTOR, FINANCE - PAO | 0 | $7.21 | -$99.67K | SELL-OPTIONS | 0.00% | 11.198K | Dec 01 | View |
| Dec 02, 2022 | Jon Stonehouse | PRESIDENT & CEO | 0 | $7.18 | -$3.43M | SELL-OPTIONS | 0.00% | 906.83K | Dec 01 - Dec 02 | View |
| Nov 16, 2022 | Yarlagadda Babu | CHIEF DISCOVERY OFFICER | 68.485K | $7.65 | -$295.43K | SELL-OPTIONS | 29.77% | 298.541K | Nov 14 | View |
| Apr 20, 2022 | GEORGE ABERCROMBIE | DIRECTOR | 0 | $7.18 | -$38.60K | SELL-OPTIONS | 0.00% | 0 | Apr 18 | View |
| Apr 04, 2022 | Helen Thackray | CHIEF R&D OFFICER | -7.6K | $16.20 | -$123.12K | SELL | -5.28% | 136.4K | Apr 01 | View |
| Mar 14, 2022 | William Sheridan | CHIEF MEDICAL OFFICER | -12.837K | $10.05 | -$2.24M | SELL | -25.27% | 37.954K | Mar 10 | View |
| Mar 09, 2022 | Yarlagadda Babu | CHIEF DISCOVERY OFFICER | -20K | $17.16 | -$343.20K | SELL | -8.00% | 230.056K | Mar 07 | View |
| Mar 03, 2022 | Michael L Jones | EXEC. DIRECTOR, FINANCE - PAO | 0 | $10.96 | -$28.68K | SELL-OPTIONS | 0.00% | 11.198K | Mar 01 | View |
| Feb 16, 2022 | GEORGE ABERCROMBIE | DIRECTOR | 0 | $10.91 | -$75.90K | SELL-OPTIONS | 0.00% | 0 | Feb 15 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.